2016 ACR/ARHP Annual Meeting

November 11-16, 2016. Washington, DC.

View by Number View by Title View Sessions

View by Date

Sunday, November 13, 2016

9:00AM-11:00AM: Epidemiology and Public Health - Poster I

9:00AM-11:00AM: Fibromyalgia, Soft Tissue Disorders, Regional and Specific Clinical Pain Syndromes - Poster I: Basic Science Focus

9:00AM-11:00AM: Genetics, Genomics and Proteomics - Poster I

9:00AM-11:00AM: Health Services Research - ARHP Poster

9:00AM-11:00AM: Health Services Research - Poster I

9:00AM-11:00AM: Healthcare Disparities in Rheumatology - Poster I

9:00AM-11:00AM: Imaging of Rheumatic Diseases - Poster I: Ultrasound and Emerging Technologies

9:00AM-11:00AM: Innate Immunity and Rheumatic Disease - Poster I

9:00AM-11:00AM: Metabolic and Crystal Arthropathies - Poster I: Clinical Practice

9:00AM-11:00AM: Miscellaneous Rheumatic and Inflammatory Diseases - Poster I

9:00AM-11:00AM: Muscle Biology, Myositis and Myopathies - Poster I: Basic/Translational

9:00AM-11:00AM: Osteoarthritis – Clinical Aspects - ARHP Poster

9:00AM-11:00AM: Osteoarthritis – Clinical Aspects - Poster I

9:00AM-11:00AM: Osteoporosis and Metabolic Bone Disease – Clinical Aspects and Pathogenesis - Poster

9:00AM-11:00AM: Pain – Basic and Clinical Aspects - Poster

9:00AM-11:00AM: Pain – Clinical Aspects - ARHP Poster

9:00AM-11:00AM: Pediatric Rheumatology – Clinical and Therapeutic Aspects - Poster I: Juvenile Idiopathic Arthritis, Uveitis

9:00AM-11:00AM: Quality Measures and Quality of Care - ARHP Poster

9:00AM-11:00AM: Quality Measures and Quality of Care - Poster I

9:00AM-11:00AM: Rheumatoid Arthritis – Animal Models - Poster I

9:00AM-11:00AM: Rheumatoid Arthritis – Clinical Aspects - ARHP Poster

9:00AM-11:00AM: Rheumatoid Arthritis – Clinical Aspects - Poster I: Clinical Characteristics/Presentation/Prognosis

9:00AM-11:00AM: Rheumatoid Arthritis – Human Etiology and Pathogenesis - Poster I

9:00AM-11:00AM: Rheumatoid Arthritis – Small Molecules, Biologics and Gene Therapy - Poster I

9:00AM-11:00AM: Sjögren's Syndrome - Poster I: Translational Science

9:00AM-11:00AM: Spondylarthropathies and Psoriatic Arthritis – Clinical Aspects and Treatment - Poster I: Axial and Peripheral Spondyloarthritis – Clinical Aspects, Imaging and Treatment

9:00AM-11:00AM: Systemic Lupus Erythematosus – Clinical Aspects and Treatment - Poster I: Clinical Trial Design and Current Therapies

9:00AM-11:00AM: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's – Pathogenesis, Animal Models and Genetics - Poster I

9:00AM-11:00AM: Systemic Sclerosis, Fibrosing Syndromes, and Raynaud's – Clinical Aspects and Therapeutics - Poster I

9:00AM-11:00AM: Vasculitis - Poster I: Large Vessel Vasculitis and Polymyalgia Rheumatica

11:00AM-12:30PM: Plenary Session I: Discovery 2016

2:30PM-4:00PM: ARHP I: Exemplary Abstracts

2:30PM-4:00PM: B Cell Biology and Targets in Autoimmune Disease I

2:30PM-4:00PM: Cytokines, Mediators, Cell-Cell Adhesion, Cell Trafficking and Angiogenesis I

2:30PM-4:00PM: Health Services Research I: Workforce and Quality of Care in Rheumatology

2:30PM-4:00PM: Imaging of Rheumatic Diseases I: Advanced Imaging in RA and Spondyloarthritides

2:30PM-4:00PM: Miscellaneous Rheumatic and Inflammatory Diseases I

2:30PM-4:00PM: Pediatric Rheumatology – Clinical and Therapeutic Aspects I: Juvenile Arthritis

2:30PM-4:00PM: Rheumatoid Arthritis – Small Molecules, Biologics and Gene Therapy I: Treatment Strategies

2:30PM-4:00PM: Spondylarthropathies and Psoriatic Arthritis – Clinical Aspects and Treatment I: Psoriatic Arthritis – Treatment

2:30PM-4:00PM: Systemic Lupus Erythematosus – Clinical Aspects and Treatment I: Nephritis

2:30PM-4:00PM: Systemic Sclerosis, Fibrosing Syndromes, and Raynaud's – Clinical Aspects and Therapeutics I

2:30PM-4:00PM: Vasculitis I: Novel Approaches to Therapy

4:30PM-6:00PM: ARHP II: Healthcare Disparities and and Psychosocial Impact on Rheumatic Disease

4:30PM-6:00PM: Epidemiology and Public Health I: Inflammatory Arthritis – Risk and Impact

4:30PM-6:00PM: Fibromyalgia, Soft Tissue Disorders, Regional and Specific Clinical Pain Syndromes

4:30PM-6:00PM: Infection-related Rheumatic Disease

4:30PM-6:00PM: Innate Immunity and Rheumatic Disease

4:30PM-6:00PM: Muscle Biology, Myositis and Myopathies

4:30PM-6:00PM: Osteoarthritis – Clinical Aspects I: Epidemiology and Progression

4:30PM-6:00PM: Osteoporosis and Metabolic Bone Disease – Clinical Aspects and Pathogenesis

4:30PM-6:00PM: Rheumatoid Arthritis – Animal Models I

4:30PM-6:00PM: Rheumatoid Arthritis – Clinical Aspects I: Pre-RA and Progression to Rheumatoid Arthritis

4:30PM-6:00PM: Spondylarthropathies and Psoriatic Arthritis – Clinical Aspects and Treatment II: Axial Spondyloarthritis – Treatment

4:30PM-6:00PM: Systemic Lupus Erythematosus – Clinical Aspects and Treatment II: Clinical Trial Design

Monday, November 14, 2016

9:00AM-11:00AM: Antiphospholipid Syndrome - Poster I

9:00AM-11:00AM: B Cell Biology and Targets in Autoimmune Disease - Poster I: SLE and Sjögren's

9:00AM-11:00AM: Biology and Pathology of Bone and Joint - Poster II

9:00AM-11:00AM: Cytokines, Mediators, Cell-Cell Adhesion, Cell Trafficking and Angiogenesis - Poster I

9:00AM-11:00AM: Education - ARHP Poster

9:00AM-11:00AM: Education - Poster

9:00AM-11:00AM: Epidemiology and Public Health - Poster II

9:00AM-11:00AM: Genetics, Genomics and Proteomics - Poster II

9:00AM-11:00AM: Health Services Research - Poster II

9:00AM-11:00AM: Healthcare Disparities in Rheumatology - ARHP Poster

9:00AM-11:00AM: Healthcare Disparities in Rheumatology - Poster II

9:00AM-11:00AM: Imaging of Rheumatic Diseases - Poster II: XR/CT/PET/MRI

9:00AM-11:00AM: Infection-related Rheumatic Disease - Poster

9:00AM-11:00AM: Miscellaneous Rheumatic and Inflammatory Diseases - Poster II

9:00AM-11:00AM: Pediatric Rheumatology – Clinical and Therapeutic Aspects - ARHP Poster

9:00AM-11:00AM: Pediatric Rheumatology – Clinical and Therapeutic Aspects - Poster II: Myositis, Systemic Lupus Erythematosus, Sjögren's Syndrome

9:00AM-11:00AM: Quality Measures and Quality of Care - Poster II

9:00AM-11:00AM: Rheumatoid Arthritis – Animal Models - Poster II

9:00AM-11:00AM: Rheumatoid Arthritis – Clinical Aspects - Poster II: Co-morbidities and Complications

9:00AM-11:00AM: Rheumatoid Arthritis – Human Etiology and Pathogenesis - Poster II

9:00AM-11:00AM: Rheumatoid Arthritis – Small Molecules, Biologics and Gene Therapy - ARHP Poster

9:00AM-11:00AM: Rheumatoid Arthritis – Small Molecules, Biologics and Gene Therapy - Poster II

9:00AM-11:00AM: Spondylarthropathies and Psoriatic Arthritis – Clinical Aspects and Treatment - Poster II: Psoriatic Arthritis

9:00AM-11:00AM: Spondylarthropathies Psoriatic Arthritis – Pathogenesis, Etiology - Poster I

9:00AM-11:00AM: Spondyloarthropathies and Psoriatic Arthritis – Clinical Aspects and Treatment - ARHP Poster

9:00AM-11:00AM: Systemic Lupus Erythematosus – Animal Models - Poster I

9:00AM-11:00AM: Systemic Lupus Erythematosus – Clinical Aspects and Treatment - Poster II: Damage Accrual and Quality of Life

9:00AM-11:00AM: Systemic Lupus Erythematosus – Human Etiology and Pathogenesis - Poster I

9:00AM-11:00AM: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's – Pathogenesis, Animal Models and Genetics - Poster II

9:00AM-11:00AM: Systemic Sclerosis, Fibrosing Syndromes, and Raynaud's – Clinical Aspects and Therapeutics - Poster II

9:00AM-11:00AM: T Cell Biology and Targets in Autoimmune Disease - Poster Session I

9:00AM-11:00AM: Vasculitis - Poster II: ANCA-Associated Vasculitis

11:00AM-12:30PM: Plenary Session II: Discovery 2016

2:30PM-4:00PM: Antiphospholipid Syndrome

2:30PM-4:00PM: ARHP III: Education and Community Programs

2:30PM-4:00PM: Healthcare Disparities in Rheumatology

2:30PM-4:00PM: Imaging of Rheumatic Diseases II: Ultrasound in Rheumatoid Arthritis

2:30PM-4:00PM: Pain – Basic and Clinical Aspects

2:30PM-4:00PM: Pediatric Rheumatology – Pathogenesis and Genetics

2:30PM-4:00PM: Rheumatoid Arthritis – Clinical Aspects II: Risk and Impact of Comorbidity

2:30PM-4:00PM: Rheumatoid Arthritis – Small Molecules, Biologics and Gene Therapy II: Safety and Cost Effectiveness

2:30PM-4:00PM: Spondylarthropathies and Psoriatic Arthritis – Clinical Aspects and Treatment III: Axial Spondyloarthritis – Clinical

2:30PM-4:00PM: Systemic Lupus Erythematosus – Clinical Aspects and Treatment III: Novel and Current Therapies

2:30PM-4:00PM: Systemic Sclerosis, Fibrosing Syndromes, and Raynaud's – Clinical Aspects and Therapeutics II

4:30PM-6:00PM: ACR/ARHP Combined Abstract Session: Epidemiology and Pubic Health

4:30PM-6:00PM: ARHP IV: Clinical Practice, Patient Care and Health Services

4:30PM-6:00PM: Genetics, Genomics and Proteomics I

4:30PM-6:00PM: Quality Measures and Quality of Care I

4:30PM-6:00PM: Reproductive Issues in Rheumatic Disorders

4:30PM-6:00PM: Rheumatoid Arthritis – Clinical Aspects III: Prevention of Comorbidity

4:30PM-6:00PM: Systemic Lupus Erythematosus – Animal Models

4:30PM-6:00PM: Systemic Lupus Erythematosus – Human Etiology and Pathogenesis I

4:30PM-6:00PM: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's – Pathogenesis, Animal Models and Genetics I

4:30PM-6:00PM: Vasculitis II: Population Studies

Tuesday, November 15, 2016

9:00AM-11:00AM: ACR Late-Breaking Poster Session

9:00AM-11:00AM: Antiphospholipid Syndrome - Poster II

9:00AM-11:00AM: B Cell Biology and Targets in Autoimmune Disease - Poster II: Rheumatoid Arthritis and Other Rheumatic Diseases

9:00AM-11:00AM: Biology and Pathology of Bone and Joint - Poster I

9:00AM-11:00AM: Cytokines, Mediators, Cell-Cell Adhesion, Cell Trafficking and Angiogenesis - Poster II

9:00AM-11:00AM: Epidemiology and Public Health - ARHP Poster

9:00AM-11:00AM: Epidemiology and Public Health - Poster III

9:00AM-11:00AM: Fibromyalgia, Soft Tissue Disorders, Regional and Specific Clinical Pain Syndromes - ARHP Poster

9:00AM-11:00AM: Fibromyalgia, Soft Tissue Disorders, Regional and Specific Clinical Pain Syndromes - Poster II: Clinical Focus

9:00AM-11:00AM: Health Services Research - Poster III

9:00AM-11:00AM: Innate Immunity and Rheumatic Disease - Poster II

9:00AM-11:00AM: Metabolic and Crystal Arthropathies - Poster II: Epidemiology and Mechanisms of Disease

9:00AM-11:00AM: Muscle Biology, Myositis and Myopathies - Poster II: Clinical

9:00AM-11:00AM: Orthopedics, Low Back Pain and Rehabilitation - ARHP Poster

9:00AM-11:00AM: Orthopedics, Low Back Pain and Rehabilitation - Poster

9:00AM-11:00AM: Osteoarthritis – Clinical Aspects - Poster II

9:00AM-11:00AM: Pediatric Rheumatology – Clinical and Therapeutic Aspects - Poster III: Systemic JIA, Autoinflammatory Syndromes, Scleroderma, Vasculitis, Miscellaneous

9:00AM-11:00AM: Pediatric Rheumatology – Pathogenesis and Genetics - Poster

9:00AM-11:00AM: Reproductive Issues in Rheumatic Disorders - Poster

9:00AM-11:00AM: Rheumatoid Arthritis – Clinical Aspects - Poster III: Treatment – Monitoring, Outcomes, Adverse Events

9:00AM-11:00AM: Rheumatoid Arthritis – Human Etiology and Pathogenesis - Poster III

9:00AM-11:00AM: Rheumatoid Arthritis – Small Molecules, Biologics and Gene Therapy - Poster III

9:00AM-11:00AM: Sjögren's Syndrome - Poster II: Clinical Science

9:00AM-11:00AM: Spondylarthropathies and Psoriatic Arthritis – Clinical Aspects and Treatment - Poster III

9:00AM-11:00AM: Spondylarthropathies Psoriatic Arthritis – Pathogenesis, Etiology - Poster II

9:00AM-11:00AM: Systemic Lupus Erythematosus – Animal Models - Poster II

9:00AM-11:00AM: Systemic Lupus Erythematosus – Clinical Aspects and Treatment - ARHP Poster

9:00AM-11:00AM: Systemic Lupus Erythematosus – Clinical Aspects and Treatment - Poster III: Biomarkers and Nephritis

9:00AM-11:00AM: Systemic Lupus Erythematosus – Human Etiology and Pathogenesis - Poster II

9:00AM-11:00AM: Systemic Sclerosis, Fibrosing Syndromes, and Raynaud's – Clinical Aspects and Therapeutics - Poster III

9:00AM-11:00AM: T Cell Biology and Targets in Autoimmune Disease - Poster Session II

9:00AM-11:00AM: Vasculitis - Poster III: Rarer Vasculitides

11:00AM-12:30PM: Plenary Session III: Discovery 2016

2:30PM-4:00PM: 2016 Rheumatology Research Foundation Edmond L. Dubois, MD Memorial Lectureship

2:30PM-4:00PM: ARHP V: Epidemiology and Public Health

2:30PM-4:00PM: Biology and Pathology of Bone and Joint

2:30PM-4:00PM: Orthopedics, Low Back Pain and Rehabilitation

2:30PM-4:00PM: Pediatric Rheumatology – Clinical and Therapeutic Aspects II: Juvenile Arthritis

2:30PM-4:00PM: Rheumatoid Arthritis – Clinical Aspects IV: Managing Patients in Remission

2:30PM-4:00PM: Rheumatoid Arthritis – Human Etiology and Pathogenesis I

2:30PM-4:00PM: Rheumatoid Arthritis – Small Molecules, Biologics and Gene Therapy III: Small Molecules and Early Intervention

2:30PM-4:00PM: Sjögren's Syndrome I: Clinical Insights

2:30PM-4:00PM: Spondylarthropathies Psoriatic Arthritis – Pathogenesis, Etiology I

2:30PM-4:00PM: Vasculitis III: Pathogenic Mechanisms

4:30PM-6:00PM: ACR Late-breaking Abstract Session

4:30PM-6:00PM: ACR/ARHP Combined Abstract Session: Orthopedics and Rehabilitation

4:30PM-6:00PM: Education

4:30PM-6:00PM: Epidemiology and Public Health II: Obesity, Cancer and Mortality

4:30PM-6:00PM: Metabolic and Crystal Arthropathies I: Mechanisms of Disease

4:30PM-6:00PM: Miscellaneous Rheumatic and Inflammatory Diseases II

4:30PM-6:00PM: Rheumatoid Arthritis – Clinical Aspects V: Challenges in the Assessment and Management of Established RA

4:30PM-6:00PM: Rheumatoid Arthritis – Small Molecules, Biologics and Gene Therapy IV: Biomarkers

4:30PM-6:00PM: Spondylarthropathies and Psoriatic Arthritis – Clinical Aspects and Treatment IV: Psoriatic Arthritis – Clinical

4:30PM-6:00PM: Systemic Lupus Erythematosus – Clinical Aspects and Treatment IV: Biomarkers

4:30PM-6:00PM: T Cell Biology and Targets in Autoimmune Disease - Oral Session

Wednesday, November 16, 2016

9:00AM-10:30AM: ACR/ARHP Combined Abstract Session: Pediatric Rheumatology

9:00AM-10:30AM: Genetics, Genomics and Proteomics II

9:00AM-10:30AM: Metabolic and Crystal Arthropathies II: Clinical Practice

9:00AM-10:30AM: Osteoarthritis – Clinical Aspect II: Treatment and Imaging

9:00AM-10:30AM: Quality Measures and Quality of Care II

9:00AM-10:30AM: Rheumatoid Arthritis – Animal Models II

9:00AM-10:30AM: Rheumatoid Arthritis – Clinical Aspects VI: Management of Early Rheumatoid Arthritis

9:00AM-10:30AM: Spondylarthropathies and Psoriatic Arthritis – Clinical Aspects and Treatment V: Imaging of Spondyloarthritis

9:00AM-10:30AM: Spondylarthropathies Psoriatic Arthritis – Pathogenesis, Etiology II

9:00AM-10:30AM: Systemic Lupus Erythematosus – Clinical Aspects and Treatment V: Damage and Morbidity

9:00AM-10:30AM: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's – Pathogenesis, Animal Models and Genetics II

9:00AM-10:30AM: Vasculitis IV: Diagnosis and Assessment of Disease Activity

11:00AM-12:30PM: ARHP VI: Rehabilitation Sciences

11:00AM-12:30PM: Epidemiology and Public Health III: Psoriatic Arthritis and More

11:00AM-12:30PM: Health Services Research II

11:00AM-12:30PM: Imaging of Rheumatic Diseases III: Crystal Arthritis, Osteoarthritis, Connective Tissue Disease and Vasculitis

11:00AM-12:30PM: Pediatric Rheumatology – Clinical and Therapeutic Aspects III: Autoinflammatory Diseases and Juvenile Dermatomyositis

11:00AM-12:30PM: Rheumatoid Arthritis – Clinical Aspects VII: The Impact of Treating to Target

11:00AM-12:30PM: Rheumatoid Arthritis – Human Etiology and Pathogenesis II

11:00AM-12:30PM: Rheumatoid Arthritis – Small Molecules, Biologics and Gene Therapy V: New Biologics and Remission Induction

11:00AM-12:30PM: Sjögren's Syndrome II: Basic Insights

11:00AM-12:30PM: Systemic Lupus Erythematosus – Clinical Aspects and Treatment VI: Quality of Life

11:00AM-12:30PM: Systemic Lupus Erythematosus – Human Etiology and Pathogenesis II

11:00AM-12:30PM: Systemic Sclerosis, Fibrosing Syndromes, and Raynaud's – Clinical Aspects and Therapeutics III

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].